Editor’s Choice
Main Category: HIV / AIDS
Also Included In: Pediatrics / Children’s Health
Article Date: 27 Apr 2012 – 10:00 PDT

email to a friend   printer friendly   opinions  

<!– rate article

Patient / Public:

Healthcare Prof:

Long-term results of the Breastfeeding, Antiretrovirals, and Nutrition (BAN) randomized trial reveals that breastfeeding for a longer period along (6+ months) with antiretroviral therapy (ART) could help reduce mother-to-child HIV transmission as well as improve chances of infant’s survival.

Children are not protected from HIV infection, however, if breastfeeding is stopped before 6 months, the risk of growth problems, illness and mortality is increased.

In an associated comment, Louise Kuhn from Columbia University, New York, USA, and Hoosen Coovadia from the University of Witwatersrand, Johannesburg, South Africa, write:

“BAN re-emphasizes that breastfeeding is essential for infant survival and wellbeing. Early weaning is neither effective nor safe as an HIV prevention strategy.”

The trial, conducted in Malawi between March 2004 and January 2010, enrolled 2,369 HIV-positive mothers and their babies. Study participants were assigned to one of three groups:

  • Maternal-antiretroviral
  • Infant-prophylaxis
  • Control group

Initial results from the trial demonstrated that HIV transmission was significantly reduced by giving antiretroviral drugs to mothers or their babies for up to 6 months. As a result, the World Health Organization (WHO) currently recommends that HIV-infected mothers or their babies receive antiretroviral prophylaxis throughout breastfeeding.

In this report, Denise Jamieson from the US Centers for Disease Control and Prevention, and her team reveal the long-term outcomes of the trial, specifically focusing on the safety and effects of weaning and stopping of antiretroviral prophylaxis at 28 weeks after birth.

The researchers found that at 48 weeks, the control group was at a significantly higher risk of HIV transmission (7%) than the infant-prophylaxis group (4%) or the maternal-antiretroviral group (4%).

In addition, the team found that early weaning, i.e. after 28 weeks, may in fact increase the chances of HIV transmission, after almost 30% of babies became infected.

Babies weaned early were also considerably more likely to develop malaria, tuberculosis, diarrhea, have growth problems or die. During the 29-48 week follow-up period, the rate of serious adverse events in babies was significantly higher than the 28-week intervention phase.
During the 48-week follow-up, 1 mother in the maternal-antiretroviral group died vs. 8 in the control group, indicating that ART might contribute to improved maternal survival.

The researchers conclude:

“Infant or maternal prophylaxis effectively reduces postnatal HIV-1 transmission and this protective effect persists until after breastfeeding is stopped.

However, transmission does occur after mothers report that they have weaned their infants, so breastfeeding with prophylaxis for longer than 28 weeks might be advantageous.

Infant morbidity and mortality also increased after 28, suggesting that continued breastfeeding with prophylaxis given for an extended period could improve infant survival.”

Written By Grace Rattue

Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA


Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

‘Breastfeeding For Longer Plus Extended ART May Reduce Mother-To-Child HIV Transmission’

Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.

Article source: http://www.medicalnewstoday.com/articles/244713.php

 

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

TEAM 25:40
Help become part of the solution by running for 25:40. As a fundraising partner this is your place to share your story about your race, discover races in your area, and network with likeminded people.
THE AIDS IMPACT
The Sub-Saharan AIDS epidemic has a devastating effect on millions of families. Consider that 5.3 million adults and children live with HIV/AIDS in South Africa alone. Discover the hard facts about AIDS, and help become a part of the solution.
CURRENT PROJECTS
25:40’s current focus is on children living in rural areas of South Africa’s Eastern Cape. We have selected this area as our place of initial focus due to its extreme poverty, lack of resources and lack of attention from the outside world.